1 |
Mangold KA, Santiano K, Broekman R, Krafft CA, Voss B, Wang V, et al. Real-time detection of blaKPC in clinical samples and surveillance specimens. J Clin Microbiol. 2011;49:3338-3339. https://doi.org/10.1128/JCM.00268-11
DOI
|
2 |
Tawfick MM, Alshareef WA, Bendary HA, Elmahalawy H, Abdulall AK. The emergence of carbapenemase blaNDM genotype among carbapenem-resistant Enterobacteriaceae isolates from Egyptian cancer patients. Eur J Clin Microbiol Infect Dis. 2020;39:1251-1259. https://doi.org/10.1007/s10096-020-03839-2
DOI
|
3 |
Feil EJ. Enterobacteriaceae: joining the dots with pan-European epidemiology. Lancet Infect Dis. 2016;17:118-119. https://doi.org/10.1016/S1473-3099(16)30333-4
DOI
|
4 |
Weiner LM, Webb AK, Limbago B, Dudeck MA, Patel J, Kallen AJ, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2011-2014. Infect Control Hosp Epidemiol. 2016;37:1288-1301. https://doi.org/10.1017/ice.2016.174
DOI
|
5 |
van Duin D, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence. 2016;8:460-469. https://doi.org/10.1080/21505594.2016.1222343
DOI
|
6 |
Han R, Shi Q, Wu S, Yin D, Peng M, Dong D, et. al. Dissemination of carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) among carbapenem-resistant Enterobacteriaceae isolated from adult and children patients in China. Front Cell Infect Microbiol. 2020;10:314. https://doi.org/10.3389/fcimb.2020.00314
DOI
|
7 |
World Health Organization. New report calls for urgent action to avert antimicrobial resistance crisis. [Internet]. New York: World Health Organization; 2019[cited 2022 March 22]. Available from: https://www.who.int/news/item/29-04-2019-new-report-calls-for-urgent-action-to-avert-antimicrobial-resistance-crisis.
|
8 |
Li J, Bi W, Dong G, Zhang Y, Wu Q, Dong T, et al. The new perspective of old antibiotic: in vitro antibacterial activity of TMP-SMZ against Klebsiella pneumoniae. J Microbiol Immunol Infect. 2020;53:757-765. https://doi.org/10.1016/j.jmii.2018.12.013
DOI
|
9 |
Wang CH, Ma L, Huang LY, Yeh KM, Lin JC, Siu LK, et al. Molecular epidemiology and resistance patterns of bla OXA-48 Klebsiella pneumoniae and Escherichia coli: a nationwide multicenter study in Taiwan. J Microbiol Immunol Infect. 2021;54: 665-672. https://doi.org/10.1016/j.jmii.2020.04.006
DOI
|
10 |
Chen HY, Jean SS, Lee YL, Lu MC, Ko WC, Liu PY, et al. Carbapenem-resistant Enterobacterales in long-term care facilities: a global and narrative review. Front Cell Infect Microbiol. 2021;11:601968. https://doi.org/10.3389/fcimb.2021.601968
DOI
|
11 |
Leavitt A, Chmelnitsky I, Carmeli Y, Navon-Venezia S. Complete nucleotide sequence of KPC-3-encoding plasmid pKpQIL in the epidemic Klebsiella pneumoniae sequence type 258. Antimicrob Agents Chemother. 2010;54:4493-4496. https://doi.org/10.1128/AAC.00175-10
DOI
|
12 |
Walther-Rasmussen, J, Hoiby N. Class A carbapenemases. J Antimicrob Chemother. 2007;60:470-482. https://doi.org/10.1093/jac/dkm226
DOI
|
13 |
Yoon EJ, Jeong SH. Mobile carbapenemase genes in Pseudomonas aeruginosa. Front Microbiol. 2021;12:614058. https://doi.org/10.3389/fmicb.2021.614058
DOI
|
14 |
Kosykowska E, Dzieciatkowski T, Mlynarczyk G. Rapid detection of NDM, VIM, KPC and IMP carbapenemases by real-time PCR. J Bacteriol Parasitol. 2016;7:6. https://doi.org/10.4172/2155-9597.1000299
DOI
|
15 |
Thyrum PT, Yeh C, Birmingham B, Lasseter K. Pharmacokinetics of meropenem in patients with liver disease. Clin. Infect. Dis. 1997; 24:184-190. https://doi.org/10.1093/clinids/24.supplement_2.s184
DOI
|
16 |
Deshpande LM, Jones RN, Fritsche TR, Sader HS. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: Report from the SENTRY antimicrobial surveillance program (2000-2004). Microb Drug Resist. 2006;12:223-230. https://doi.org/10.1089/mdr.2006.12.223
DOI
|
17 |
Poirel L, Revathi G, Bernabeu S, Nordmann P. Detection of NDM-1-Producing Klebsiella pneumoniae in Kenya. Antimicrob Agents Chemother. 2011;55:934-936. https://doi.org/10.1128/AAC.01247-10
DOI
|
18 |
Doyle D, Peirano G, Lascols C, Lloyd T, Church DL, Pitout JD. Laboratory detection of Enterobacteriaceae that produce carbapenemases. J Clin Microbiol. 2012;50:3877-3880. https://doi.org/10.1128/JCM.02117-12
DOI
|
19 |
Wang L, Gu H, Lu X. A rapid low-cost real-time PCR for the de-tection of Klebsiella pneumonia carbapenemase genes. Ann Clin Microbiol Antimicrob. 2012;11:9. https://doi.org/10.1186/1476-0711-11-9
DOI
|
20 |
Bordin A, Trembizki E, Windsor M, Wee R, Tan LY, Buckley C, et al. Evaluation of the SpeeDx Carba (beta) multiplex real-time PCR assay for detection of NDM, KPC, OXA-48-like, IMP-4-like and VIM carbapenemase genes. BMC Infect Dis. 2019;19:571. https://doi.org/10.1186/s12879-019-4176-z
DOI
|
21 |
Choi IH, Lee YS. Active surveillance for carbapenem-resistant Enterobacteriaceae at a single center for four years. Ann Lab Med. 2022;42:367-369. https://doi.org/10.3343/alm.2022.42.3.367
DOI
|
22 |
Tamma PD, Simner PJ. Phenotypic detection of carbapenemase producing organisms from clinical isolates. J Clin Microbiol. 2018;56:e01140-18. https://doi.org/10.1128/JCM.01140-18
DOI
|
23 |
Mutters NT, Tacconelli E. Infection prevention and control in Europe-the picture in the mosaic. Clin Microbiol Infect. 2015;21:1045-1046. https://doi.org/10.1016/j.cmi.2015.06.012
DOI
|
24 |
Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement M100-S27. Wayne PA: Clinical Laboratory Standards Institute; 2017.
|
25 |
Moquet O, Bouchiat C, Kinana A, Seck A, Arouna O, Bercion R, et al. Class D OXA-48 carbapenemasein multidrug-resistant enterobacteria, Senegal. Emerg Infect Dis. 2011;17:143-144. https://doi.org/10.3201/eid1701.100244
DOI
|
26 |
Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother. 2012;67:1597-606. https://doi.org/10.1093/jac/dks121
DOI
|
27 |
Yang BS, Park JA. Detection of bla KPC and bla NDM genes from gram-negative rod bacteria isolated from a general hospital in Gyeongnam. Korean J Clin Lab Sci. 2021;53:49-59. https://doi.org/10.15324/kjcls.2021.53.1.49
DOI
|
28 |
El Solh AA, Alhajhusain A. Update on the treatment of Pseudomonas aeruginosa pneumonia. J Antimicrob Chemother. 2009;64:229-238. https://doi.org/10.1093/jac/dkp201
DOI
|
29 |
Sheu CC, Chang YT, Lin SY, Chen YH, Hsueh PR. Infections caused by carbapenem-resistant Enterobacteriaceae: an update on therapeutic options. Front Microbiol. 2019;10:80. https://doi.org/10.3389/fmicb.2019.00080
DOI
|
30 |
Lin MY, Lyles-Banks RD, Lolans K, Hines DW, Spear JB, Petrak R, et al. The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis. 2013;57: 1246-52. https://doi.org/10.1093/cid/cit500
DOI
|
31 |
Lee KW, Kim CK, Yong DE, Jeong SH, Yum JH, Seo YH, et al. Improved performance of the modified Hodge test with MacConkey agar for screening carbapenemase-producing Gram-negative bacilli. J Microbiol Methods. 2010;83:149-152. https://doi.org/10.1016/j.mimet.2010.08.010
DOI
|
32 |
The Korean Society of Clinical Microbiology. Diagnostic instruction carbapenemase producing Enterobacteriaceae (CPE) [Internet]. Seoul: The Korean Society of Clinical Microbiology; 2015 [cited 2022 May 19]. Available from: http://kscm.or.kr/xe/kscmnotice/71241.
|
33 |
Monteiro J, Widen RH, Pignatari ACC, Kubasek C, Silbert S. Rapid detection of carbapenemase genes by multiplex real-time PCR. J Antimicrob Chemother. 2012;67:906-909. https://doi.org/10.1093/jac/dkr563
DOI
|
34 |
Aurilio C, Sansone P, Barbarisi M, Pota V, Giaccari LG, Coppolino F, et al. Mechanisms of action of carbapenem resistance. Antibiotics. 2022;11:421. https://doi.org/10.3390/antibiotics11030421
DOI
|
35 |
Goodman KE, Simner PJ, Tamma PD, Milstone AM. Infection control implications of heterogeneous resistance mechanisms in carbapenem resistant Enterobacteriaceae (CRE). Expert Rev Anti Infect Ther. 2016;14:95-108. https://doi.org/10.1007/10.1586/14787210.2016.1106940
DOI
|
36 |
Zhang H, Jia P, Zhu Y, Zhang G, Zhang J, Kang W, et al. Susceptibility to imipenem/relebactam of Pseudomonas aeruginosa and Acinetobacter baumannii isolates from Chinese intra-abdominal, respiratory and urinary tract infections: SMART 2015 to 2018. Infect. Drug Resist. 2021;14:3509-3518. https://doi.org/10.2147/IDR.S325520
DOI
|
37 |
Jean SS, Harnod D, Hsueh PR. Global threat of carbapenem resistant gram-negative bacteria. Front Cell Infect Microbiol. 2022;12:823684. https://doi.org/10.3389/fcimb.2022.823684
DOI
|
38 |
Diene SM, Rolain JM. Carbapenemase genes and genetic platforms in Gram-negative bacilli: Enterobacteriaceae, Pseudomonas and Acinetobacter species. Clin Microbiol Infect. 2014;20:831-838. https://doi.org/10.1111/1469-0691.12655
DOI
|
39 |
Potron A, Poirel L, Nordmann P. Emerging broad-spectrum resistance to Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology. Int J Antimicrob Agents. 2015;45:568-585. https://doi.org/10.1016/j.ijantimicag.2015.03.001
DOI
|
40 |
Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing β-Lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45: 1151-1161. https://doi.org/10.1128/AAC.45.4.1151-1161.2001
DOI
|
41 |
Banerjee R, Humphries R. Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae. Virulence. 2017;8:427-439. https://doi.org/10.1080/21505594.2016.1185577
DOI
|
42 |
Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother. 2011;66:307-312. https://doi.org/10.1093/jac/dkq431
DOI
|
43 |
Frere JM, Galleni M, Bush K, Dideberg O. Is it necessary to change the classification of beta-lactamases? J Antimicrob Chemother. 2005;55:1051-1053. https://doi.org/10.1093/jac/dki155
DOI
|
44 |
Queenan AM, Bush K. Carbapenemases: the versatile be- ta-lactamases. Clin Microbiol Rev. 2007;20:440-458. https://doi.org/10.1128/CMR.00001-07
DOI
|
45 |
Goudarzi H, Mirsamadi ES, Ghalavand Z, Vala MH, Mirjalali H, Hashemi A. Rapid detection and molecular survey of blaVIM, blaIMP and blaNDM genes among clinical isolates of Acinetobacter baumannii using new multiplex real-time PCR and melting curve analysis. BMC Microbiol. 2019;19:122. https://doi.org/10.1186/s12866-019-1510-y
DOI
|
46 |
Talapan D, Rafila A. Five-year survey of asymptomatic colonization with multidrug-resistant organisms in a Romanian tertiary care hospital. Infect Drug Resist. 2022;15:2959-2967. https://doi.org/10.2147/IDR.S360048
DOI
|